Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.3768
-0.0212 (-5.33%)
At close: May 29, 2025, 4:00 PM
0.3990
+0.0222 (5.89%)
After-hours: May 29, 2025, 8:00 PM EDT
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $12.66 million as of May 29, 2025. Its market cap has increased by 9.55% in one year.
Market Cap
12.66M
Enterprise Value
6.99M
1-Year Change
9.55%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $12.66M, a decrease of -95.38%. That is a compound annual growth rate of -57.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2025 | 13.37M | -39.81% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.06B |
| Johnson & Johnson | 368.73B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 267.61B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |